Sibofimloc (Antibiotic-202) is a first-in-class, gut-restricted, orally active FimH adhesion inhibitor extracted from patent WO2014100158A1, Compound Example 202. Sibofimloc has anti-bacterial infective activity. Sibofimloc is developed for inflammatory bowel disease (IBD).

DOTA-NHS-ester is a linker for affibody molecules and is applied in small animals PET, SPECT, and CT. DOTA-NHS-ester can be used to label radiotherapeutic agents or imaging probes for the detection of tumors.

hPGDS-IN-1 is a hPGDS inhibitor ,with IC50 of 12 nM in the Fluorescence Polarization Assay or the EIA assay.IC50 value: 12 nMTarget: hPGDSThe detailed information please refer to WO2011044307A1 and WO2010080563A2

Piperacetazine (Quide, Psymod) is a potent inhibitor of PAX3::FOXO1 and a prodrug of a phenothiazine antipsychotic drug with a mechanism of action similar to chlorpromazine. Piperacetazine has antitumor activity.

TPh A (Triphenyl Compound A) is a potent inhibitor of the nuclear protein pirin and binds specifically to pirin with a Ki of 0.6 uM. TPh A disrupts the formation of the bcl3–pirin complex. TPh A can be used as a novel small molecule tool to regulate pirin in cells.

VKGILS-NH2 is a reversed amino acid sequence control peptide for SLIGKV-NH2 (protease-activated receptor 2 (PAR2) agonist). VKGILS-NH2 has no effect on DNA synthesis in cells.

L-Palmitoylcarnitine chloride is a fatty acid metabolite, accumulates in the sarcolemma and deranges the membrane lipid environment during ischaemia. It potentially inhibited the KATP channels by interacting with Kir6.2.

3-Epioleanolic acid is an active component of Verbena officinalis Linn, with anti-inflammatory activity.

Trofinetide (NNZ-2566), a synthetic analogue of the endogenous N-terminus tripeptide, Glycine-Proline-Glutamate (GPE), has been shown to be neuroprotective in animal models of brain injury.

PAR-2 (1-6) (human) (SLIGKV), a peptide ligand, is a PAR-2 agonist.